Come up with a name for your new list and we'll add to it:
Tokai Pharmaceuticals raised a round of funding on April 22, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Tokai Pharmaceuticals (NASDAQ:TKAI) is a biopharmaceutical company focused on developing and commercializing therapies for prostate cancer and other hormonally driven diseases. The company's lead drug…